Search | IOVS | ARVO Journals

Showing 1 – 20 of 31

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Effect of outdoors activities measured by biomarker CUVAF in a cohort of 2616 children (7-12 years old) of Madrid.

Sergio Recalde; Miriam de la Puente; Maria Hernandez; Aura Sofia Ortega; Macarena Dosal; David Piñero; Laura Batres-Valderas; JUAN GONZALO CARRACEDO-RODRIGUEZ; Javier García; Jesús Barrio; Alfredo Garcia-Layana; Patricia Fernandez

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):152.

ARVO Annual Meeting Abstract June 2024

Addition of CoQ 10 to a nutritional complex improves mitochondrial status in oxidative stress-induced retinal pigment epithelial cells

Patricia Fernandez; Jaione Bezunartea; Maite Moreno-Orduña; Ainara Chas-Prat; Idoia Belza-Zuazu; Maria Hernandez; Sergio Recalde; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1288.

ARVO Annual Meeting Abstract June 2023

Conjunctival autofluorescence (CUVAF) as a biomarker of outdoor exposure in the risk of childhood myopia.

Sergio Recalde; Miriam De la Puente; Maria Hernandez; Leire Gomez-Arteta; Jaione Bezunartea; Jorge Gonzalez-Zamora; Valentina Bilbao; Manuel Saenz de Viteri; Jesus Barrio-Barrio; Alfredo Garcia-Layana; Patricia Fernandez-Robredo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):810.

ARVO Annual Meeting Abstract July 2019

Role of the Matrix Metalloproteinase 10 (MMP-10) in Choroidal Neovascularization (CNV)

Maria Hernandez; Patricia Fernandez; Sergio Recalde; Jose Antonio Rodriguez; Josune Orbe; Ana Montoliu; Jaione Bezunartea; Idoia Belza; Elvira Rojas de Miguel; Jorge Gonzalez; Maite Moreno; Elena Alonso; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1249.

ARVO Annual Meeting Abstract July 2019

Intravitreal bevacizumab-loaded nanoparticles reduce choroidal neovascularization in laser-induced animal model.

Patricia Fernandez; Sergio Recalde; Maria Hernandez; Jaione Bezunartea; Juan Manuel Irache; Ines Luis de Redin; Idoia Belza; Elvira Rojas de Miguel; Maite Moreno; Elena Alonso; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1251.

ARVO Annual Meeting Abstract July 2019

The characterization of high myopic-associated SNPs in Asiatic populations in an European cohort of myopic maculopathy.

Sergio Recalde; Maria Hernandez; Valentina Bilbao; Leyre Maestre-Rellan; Idoia Belza; Elena Alonso; Jaione Bezunartea; Javier Araiz; Jose Maria Ruiz-Moreno; Patricia Fernandez; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3142.

ARVO Annual Meeting Abstract July 2018

Efficient choroidal neovascularization reduction by Sleeping Beauty Transposon-mediated PEDF gene delivery in rat iris and retinal pigment epithelial cells by using a clinical electroporator

Patricia Fernandez; Sergio Recalde; Maria Hernandez; Laura Garcia-Garcia; Jaione Bezunartea; Juan Roberto Rodriguez; Corinne Marie; Daniel Scherman; Zsuzsanna Izsvak; Martina Kropp; Sandra Johnen; Gabriele Thumann; Alfredo García-Layana

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):223.

ARVO Annual Meeting Abstract July 2018

Different gender risk distribution of CRP and A69S frequencies in wet-AMD Spanish patients

Maria Hernandez; Sergio Recalde; Javier Zarranz-Ventura; Blanca Molins; Maite Moreno; Jaione Bezunartea; Alfredo Adán; Patricia Fernandez; Alfredo García-Layana

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1427.

ARVO Annual Meeting Abstract July 2018

Recovering of inflammatory and oxidative stress damage in retinal epithelial and endothelial cells: synergistic action of anti-oxidant and vitamin D

Sergio Recalde; Maria Hernandez; Jaione Bezunartea; Maite Moreno; Idoia Belza; Alfredo García-Layana; Patricia Fernandez

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2479.

ARVO Annual Meeting Abstract June 2017

Effect of Bevacizumab, Ranibizumab and Aflibercept on retinal pigment epithelium phagocytosis

Patricia Fernandez; Maria Hernandez; Sergio Recalde; Manuel Saenz de Viteri; Idoia Belza; Maite Moreno; Jaione Bezunartea; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1207.

ARVO Annual Meeting Abstract June 2017

Rat Primary Cells transfected with PEDF using the Sleeping Beauty Transposon system are effective in reducing the proangiogenic status in choroidal neovascularization

Sergio Recalde; Maria Hernandez; Patricia Fernandez; Laura García-Garcia; Juan Roberto Rodriguez; Jaione Bezunartea; Maite Moreno; Idoia Belza; Corinne Marie; Daniel Scherman; Zsuzsanna Izsvák; Sandra Johnen; Gabriele Thumann; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1964.

ARVO Annual Meeting Abstract September 2016

Efficacy of Rat Primary Cells transfected with Pigment Epithelium-Derived Factor using the Sleeping Beauty Transposon system in choroidal neovascularization.

Maria Hernandez; Laura Garcia-Garcia; Sergio Recalde; Patricia Fernandez; Juan Roberto Rodriguez; Jaione Bezunartea-Bezunartea; Daniel Scherman; Sandra Johnen; Gabriele Thumann; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):271.

ARVO Annual Meeting Abstract September 2016

RT-qPCR quantification of mRNAs specific of Pigment Epithelium-Derived Factor (PEDF) and Vascular Endothelial Growth Factor (VEGF) in Rat eyes injected in the subretinal space with Primary Cells transfected with hPEDF.

Sergio Recalde; Laurence Jeanson-LEH; Patricia Fernandez; Maria Hernandez; Laura Garcia-Garcia; Jaione Bezunartea-Bezunartea; Daniel Scherman; Séverine Pouillot; Gabriele Thumann; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):281.

ARVO Annual Meeting Abstract September 2016

Ranibizumab, Bevacizumab, and Aflibercept accumulation and their effect on cell migration and permeability on human ARPE-19 cells

Patricia Fernandez; Manuel Saenz de Viteri; Sergio Recalde; Maria Hernandez; Jaione Bezunartea-Bezunartea; Elena Alonso; Maite Moreno-Orduna; Natalia Aguado; Idoia Belza; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3363.

ARVO Annual Meeting Abstract June 2015

Different Association of ARMS2 , CFH , CFHR1-3, SERPINF1 , VEGFR1 and C5 Polymorphisms in response of Ranibizumab treatment in wet-AMD.

Alvaro Velazquez Villoria; Sergio Recalde; Patricia Fernandez-Robredo; Carla Barreales; Esefanía Cobos; Alicia Valverde; Marta Suarez-Figueroa; Fernando Cruz; Maximino Abraldes; Alfredo Garcia Layana

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3787.

ARVO Annual Meeting Abstract June 2015

Cigarette smoke-related hydroquinone decreases C1q expression through ROS production in the RPE

Maria E Marin Castano; Mablo J Marin Carcia; Sergio Recalde; Maria Hernandez; Alfredo Garcia Layana; Retina

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4229.

ARVO Annual Meeting Abstract June 2015

Effect of EPA:DHA formulations on cell viability, proliferation and reactive oxygen species generation under inflamatory and oxidative stress conditions

Laura Garcia-Garcia; Sergio Recalde; Patricia Fernandez-Robredo; Maria Hernandez; Nahia Ispizua-Madariaga; Nicholas Reiter; Edurne Albiasu; Jaione Bezunartea; Elena Alonso; Alfredo Garcia Layana

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):16.

ARVO Annual Meeting Abstract June 2015

Biodistribution of Rat Primary Cells transfected with SB100X transposon-mediated Pigment Epithelium-Derived Factor (PEDF) gene in Brown Norway rats after subretinal injection

Maria Hernandez; Laura Garcia-Garcia; Sergio Recalde; Patricia Fernandez-Robredo; Juan Roberto Rodriguez Madoz; Daniel Sherman; Zsuzsanna Izsvák; Sandra Johnen; Gabriele Thumann; Alfredo Garcia Layana

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1835.

ARVO Annual Meeting Abstract June 2015

Toxicity Study of anti-VEGF drugs: Ranibizumab, Bevabizumab and Aflibercept on human ARPE19 cell line after single or repeated clinical doses.

Nicholas Reiter; Manuel Saenz de Viteri Vazquez; Sergio Recalde; Patricia Fernandez; Laura Garcia-Garcia; Jaione Bezunartea; Maria Hernandez; Elena Alonso; Maite Moreno; Alfredo Garcia Layana

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):216.

ARVO Annual Meeting Abstract April 2014

EFFECT OF THE ABSENCE OF BOTH, APOLIPOPROTEIN E AND COMPLEMENT FACTOR H, ON RETINAL GENE EXPRESSION, ENZYMATIC ACTIVITY AND LIPID PROFILE.

Laura Garcia-Garcia; Sergio Recalde; Patricia Fernandez; Maite Moreno-Orduña; Vanessa Fernandez-Garcia; Jaione Bezunartea-Bezunartea; Nicolas Cuenca; Pedro de la Villa; Alfredo Garcia-Layana

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1333.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Effect of outdoors activities measured by biomarker CUVAF in a cohort of 2616 children (7-12 years old) of Madrid.

Addition of CoQ 10 to a nutritional complex improves mitochondrial status in oxidative stress-induced retinal pigment epithelial cells

Conjunctival autofluorescence (CUVAF) as a biomarker of outdoor exposure in the risk of childhood myopia.

Role of the Matrix Metalloproteinase 10 (MMP-10) in Choroidal Neovascularization (CNV)

Intravitreal bevacizumab-loaded nanoparticles reduce choroidal neovascularization in laser-induced animal model.

The characterization of high myopic-associated SNPs in Asiatic populations in an European cohort of myopic maculopathy.

Efficient choroidal neovascularization reduction by Sleeping Beauty Transposon-mediated PEDF gene delivery in rat iris and retinal pigment epithelial cells by using a clinical electroporator

Different gender risk distribution of CRP and A69S frequencies in wet-AMD Spanish patients

Recovering of inflammatory and oxidative stress damage in retinal epithelial and endothelial cells: synergistic action of anti-oxidant and vitamin D

Effect of Bevacizumab, Ranibizumab and Aflibercept on retinal pigment epithelium phagocytosis

Rat Primary Cells transfected with PEDF using the Sleeping Beauty Transposon system are effective in reducing the proangiogenic status in choroidal neovascularization

Efficacy of Rat Primary Cells transfected with Pigment Epithelium-Derived Factor using the Sleeping Beauty Transposon system in choroidal neovascularization.

RT-qPCR quantification of mRNAs specific of Pigment Epithelium-Derived Factor (PEDF) and Vascular Endothelial Growth Factor (VEGF) in Rat eyes injected in the subretinal space with Primary Cells transfected with hPEDF.

Ranibizumab, Bevacizumab, and Aflibercept accumulation and their effect on cell migration and permeability on human ARPE-19 cells

Different Association of ARMS2 , CFH , CFHR1-3, SERPINF1 , VEGFR1 and C5 Polymorphisms in response of Ranibizumab treatment in wet-AMD.

Cigarette smoke-related hydroquinone decreases C1q expression through ROS production in the RPE

Effect of EPA:DHA formulations on cell viability, proliferation and reactive oxygen species generation under inflamatory and oxidative stress conditions

Biodistribution of Rat Primary Cells transfected with SB100X transposon-mediated Pigment Epithelium-Derived Factor (PEDF) gene in Brown Norway rats after subretinal injection

Toxicity Study of anti-VEGF drugs: Ranibizumab, Bevabizumab and Aflibercept on human ARPE19 cell line after single or repeated clinical doses.

EFFECT OF THE ABSENCE OF BOTH, APOLIPOPROTEIN E AND COMPLEMENT FACTOR H, ON RETINAL GENE EXPRESSION, ENZYMATIC ACTIVITY AND LIPID PROFILE.

To View More...

You must be signed into an individual account to use this feature.